Literature DB >> 16860004

Validation of an HPLC method for analysis of DB-67 and its water soluble prodrug in mouse plasma.

Jamie Horn1, Sherri L Jordan, Lin Song, Michael J Roberts, Bradley D Anderson, Markos Leggas.   

Abstract

A method for the quantitation of DB-67 ((20S)-10-hydroxy-7-tert-butyldimethylsilylcamptothecin) lactone and carboxylate in mouse plasma has been developed, validated, and applied in pharmacokinetic studies. The analytes were separated by reversed-phase chromatography with fluorescence detection. Validation demonstrated the selectivity and specificity for the carboxylate and lactone, with linearity between 1-300ng/mL and 2.5-300ng/mL for the carboxylate and lactone, respectively (accuracy 90-110% of theory and coefficient of variation < or =5.7%). Carboxylate to lactone conversion was <4% using this method. The assay was found to be suitable for the analysis of DB-67 lactone and carboxylate in pharmacokinetic studies following intravenous administration of DB-67 or its delta-aminobutyric acid ester derivative.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16860004     DOI: 10.1016/j.jchromb.2006.06.022

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  6 in total

1.  Metabolic pathways of the camptothecin analog AR-67.

Authors:  Jamie Horn; Marta Milewska; Susanne M Arnold; Markos Leggas
Journal:  Drug Metab Dispos       Date:  2010-12-28       Impact factor: 3.922

2.  Pharmacokinetic modeling to assess factors affecting the oral bioavailability of the lactone and carboxylate forms of the lipophilic camptothecin analogue AR-67 in rats.

Authors:  Eyob D Adane; Zhiwei Liu; Tian-Xiang Xiang; Bradley D Anderson; Markos Leggas
Journal:  Pharm Res       Date:  2011-11-09       Impact factor: 4.200

3.  Factors affecting the in vivo lactone stability and systemic clearance of the lipophilic camptothecin analogue AR-67.

Authors:  Eyob D Adane; Zhiwei Liu; Tian-Xiang Xiang; Bradley D Anderson; Markos Leggas
Journal:  Pharm Res       Date:  2010-04-29       Impact factor: 4.200

4.  The effect of breast cancer resistance protein, multidrug resistant protein 1, and organic anion-transporting polypeptide 1B3 on the antitumor efficacy of the lipophilic camptothecin 7-t-butyldimethylsilyl-10-hydroxycamptothecin (AR-67) in vitro.

Authors:  Eleftheria Tsakalozou; Eyob D Adane; Kuei-Ling Kuo; Abigail Daily; Jeffrey A Moscow; Markos Leggas
Journal:  Drug Metab Dispos       Date:  2013-04-25       Impact factor: 3.922

5.  An HPLC assay for the lipophilic camptothecin analog AR-67 carboxylate and lactone in human whole blood.

Authors:  Eleftheria Tsakalozou; Jamie Horn; Mark Leggas
Journal:  Biomed Chromatogr       Date:  2010-10       Impact factor: 1.902

6.  A phase I study of 7-t-butyldimethylsilyl-10-hydroxycamptothecin in adult patients with refractory or metastatic solid malignancies.

Authors:  Susanne M Arnold; John J Rinehart; Eleftheria Tsakalozou; John R Eckardt; Scott Z Fields; Brent J Shelton; Philip A DeSimone; Bryan K Kee; Jeffrey A Moscow; Markos Leggas
Journal:  Clin Cancer Res       Date:  2010-01-12       Impact factor: 12.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.